Nektar Therapeutics Inc. Revenue 2009–2025
Nektar Therapeutics Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Nektar Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 10.9 M, a 3.83% increase year-over-year.
- Nektar Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 44.3 M, a 52.58% decrease year-over-year.
- Nektar Therapeutics Inc. annual revenue for 2025 was 55.2 M, a 43.89% decrease from 2024.
- Nektar Therapeutics Inc. annual revenue for 2024 was 98.4 M, a 9.22% increase from 2023.
- Nektar Therapeutics Inc. annual revenue for 2023 was 90.1 M, a 2.10% decrease from 2022.
- Nektar Therapeutics Inc. annual revenue for 2022 was 92.1 M.
Nektar Therapeutics Inc. (NKTR) — Frequently Asked Questions
Nektar Therapeutics Inc. (NKTR) is a publicly traded US company. It has a market capitalization of $958M. In fiscal 2025 it reported revenue of $55M and net income of -$164M. Explore NKTR's stock price, financial statements, earnings history, margins and key ratios below.
What is Nektar Therapeutics Inc.'s market cap?
Nektar Therapeutics Inc. (NKTR) has a market capitalization of $958M.
What is the NKTR stock price?
NKTR trades at $56.78 (+0.98% on the day).
How much revenue does Nektar Therapeutics Inc. make?
Nektar Therapeutics Inc. reported revenue of $55M in fiscal 2025.
Is NKTR profitable?
In fiscal 2025, Nektar Therapeutics Inc. reported net income of -$164M.